AstraZeneca, Pharmaceuticals industry, China, Business, UK news Business | The Guardian
Pharmaceutical company will invest money over five years in ‘strategic partnership’ with the city’s authoritiesBusiness live – latest updatesAstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.The investment will be staggered over the next five years as part of a “strategic partnership” with the city’s authorities and also includes agreements with three local biotech companies. Continue reading…
Pharmaceutical company will invest money over five years in ‘strategic partnership’ with the city’s authorities
AstraZeneca will invest $2.5bn in research and manufacturing in Beijing, as the pharmaceutical company tries to move past recent controversies including ditching plans for the expansion of a UK vaccine plant and the detentions of top executives in China.
The investment will be staggered over the next five years as part of a “strategic partnership” with the city’s authorities and also includes agreements with three local biotech companies.
